Found: 148
Select item for more details and to access through your institution.
Portal hypertension and its prognostic implications in patients with Wilson's disease.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2024, v. 60, n. 2, p. 257, doi. 10.1111/apt.18060
- By:
- Publication type:
- Article
Editorial: ARFI‐based techniques are better than VCTE for diagnosing advanced fibrosis in severe obesity—Authors' reply.
- Published in:
- 2024
- By:
- Publication type:
- Editorial
The deep abdominal ultrasound transducer (DAX) increases the success rate and diagnostic accuracy of shear wave elastography for liver fibrosis assessment in patients with obesity—A prospective biopsy‐controlled study.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2024, v. 60, n. 1, p. 70, doi. 10.1111/apt.18019
- By:
- Publication type:
- Article
Letter: Fibrates may be safe and effective in patients with primary biliary cholangitis and decompensated cirrhosis—Authors' reply.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2024, v. 60, n. 1, p. 107, doi. 10.1111/apt.18067
- By:
- Publication type:
- Article
Statins, metformin, and RAS inhibitors did not reduce variceal bleeding risk and mortality in a large, real-life cohort of patients with cirrhosis.
- Published in:
- PLoS ONE, 2024, v. 19, n. 6, p. 1, doi. 10.1371/journal.pone.0302811
- By:
- Publication type:
- Article
Von Willebrand factor for outcome prediction within different clinical stages of advanced chronic liver disease.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2024, v. 59, n. 11, p. 1376, doi. 10.1111/apt.17945
- By:
- Publication type:
- Article
Use of the CytoSorb adsorber in patients with acute-on-chronic liver failure.
- Published in:
- Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-61658-3
- By:
- Publication type:
- Article
Editorial: Recompensation in PBC is good. But is it good enough? Authors' reply.
- Published in:
- 2024
- By:
- Publication type:
- Editorial
Clinical course of congestive hepatopathy pre/post heart transplantation.
- Published in:
- Wiener Klinische Wochenschrift, 2024, v. 136, n. 9/10, p. 267, doi. 10.1007/s00508-023-02231-2
- By:
- Publication type:
- Article
Evaluation of potential hepatic recompensation criteria in patients with PBC and decompensated cirrhosis.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2024, v. 59, n. 8, p. 962, doi. 10.1111/apt.17908
- By:
- Publication type:
- Article
Management of varices but not anticoagulation is associated with improved outcome in patients with HCC and macrovascular tumour invasion.
- Published in:
- Cancer Imaging, 2024, v. 24, p. 1, doi. 10.1186/s40644-024-00657-z
- By:
- Publication type:
- Article
Diabetes impairs the haemodynamic response to non‐selective betablockers in compensated cirrhosis and predisposes to hepatic decompensation.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2023, v. 58, n. 8, p. 805, doi. 10.1111/apt.17653
- By:
- Publication type:
- Article
Editorial: Negative impact of diabetes mellitus and obesity on the prognosis of patients with chronic liver disease—Authors' reply.
- Published in:
- 2023
- By:
- Publication type:
- Case Study
Letter: NSBB for fatty liver disease—Still a long way to go. Authors' reply.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2023, v. 58, n. 8, p. 848, doi. 10.1111/apt.17702
- By:
- Publication type:
- Article
Hepatic recompensation according to Baveno VII criteria is linked to a significant survival benefit in decompensated alcohol‐related cirrhosis.
- Published in:
- Liver International, 2023, v. 43, n. 10, p. 2220, doi. 10.1111/liv.15676
- By:
- Publication type:
- Article
Two-dimensional shear wave elastography (ElastQ) accurately rules out liver fibrosis and rules in advanced chronic liver disease across liver disease etiologies: a prospective multicenter study.
- Published in:
- Ultrasonography, 2023, v. 42, n. 4, p. 544, doi. 10.14366/usg.23069
- By:
- Publication type:
- Article
Late-stage presentation with decompensated cirrhosis is alarmingly common but successful etiologic therapy allows for favorable clinical outcomes.
- Published in:
- PLoS ONE, 2023, v. 18, n. 8, p. 1, doi. 10.1371/journal.pone.0290352
- By:
- Publication type:
- Article
Gas6 in chronic liver disease—a novel blood-based biomarker for liver fibrosis.
- Published in:
- Cell Death Discovery, 2023, v. 9, n. 1, p. 1, doi. 10.1038/s41420-023-01551-6
- By:
- Publication type:
- Article
Transplantation of hepatitis D virus patients: Lifelong hepatitis B immunoglobulins?
- Published in:
- Liver International, 2023, v. 43, n. 1, p. 96, doi. 10.1111/liv.15352
- By:
- Publication type:
- Article
Prevalence and dynamics of NAFLD-associated fibrosis in people living with HIV in Vienna from first presentation to last follow-up.
- Published in:
- Wiener Klinische Wochenschrift, 2023, v. 135, n. 15/16, p. 420, doi. 10.1007/s00508-022-02133-9
- By:
- Publication type:
- Article
Disturbances in sodium and chloride homeostasis predict outcome in stable and critically ill patients with cirrhosis.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2023, v. 58, n. 1, p. 71, doi. 10.1111/apt.17507
- By:
- Publication type:
- Article
Carvedilol as the new non‐selective beta‐blocker of choice in patients with cirrhosis and portal hypertension.
- Published in:
- Liver International, 2023, v. 43, n. 6, p. 1183, doi. 10.1111/liv.15559
- By:
- Publication type:
- Article
The rationale and study design of two phase II trials examining the effects of BI 685,509, a soluble guanylyl cyclase activator, on clinically significant portal hypertension in patients with compensated cirrhosis.
- Published in:
- Trials, 2023, v. 24, n. 1, p. 1, doi. 10.1186/s13063-023-07291-3
- By:
- Publication type:
- Article
Early changes in immunoglobulin G levels during immune checkpoint inhibitor treatment are associated with survival in hepatocellular carcinoma patients.
- Published in:
- PLoS ONE, 2023, v. 17, n. 4, p. 1, doi. 10.1371/journal.pone.0282680
- By:
- Publication type:
- Article
Bacterial growth and ceftriaxone activity in individual ascitic fluids in an in vitro model of spontaneous bacterial peritonitis.
- Published in:
- Frontiers in Pharmacology, 2023, v. 14, p. 01, doi. 10.3389/fphar.2023.1124821
- By:
- Publication type:
- Article
High Prevalence of Asymptomatic Sexually Transmitted Infections in Austrian Pre-Exposure Prophylaxis Users: A Prospective Observational Study.
- Published in:
- 2023
- By:
- Publication type:
- Letter to the Editor
Letter: chronic HDV infection—is ignorance bliss? Authors' reply.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2023, v. 57, n. 3, p. 359, doi. 10.1111/apt.17355
- By:
- Publication type:
- Article
Low Spontaneous Clearance Rates of Recently Acquired Hepatitis C Virus in Human Immunodeficiency Virus–Positive Men Who Have Sex With Men (PROBE-C Study).
- Published in:
- Clinical Infectious Diseases, 2023, v. 76, n. 3, p. e607, doi. 10.1093/cid/ciac680
- By:
- Publication type:
- Article
Imaging features facilitate diagnosis of porto-sinusoidal vascular disorder.
- Published in:
- European Radiology, 2023, v. 33, n. 2, p. 1422, doi. 10.1007/s00330-022-09132-4
- By:
- Publication type:
- Article
Author's reply: The relationship between systemic inflammation and liver fibrogenesis in patients with cirrhosis.
- Published in:
- Liver International, 2023, v. 43, n. 2, p. 520, doi. 10.1111/liv.15507
- By:
- Publication type:
- Article
Low mortality despite temporary liver dysfunction in severe courses of acute hepatitis E.
- Published in:
- Wiener Klinische Wochenschrift, 2023, v. 135, n. 3/4, p. 57, doi. 10.1007/s00508-022-02126-8
- By:
- Publication type:
- Article
The systemic and hepatic alternative renin–angiotensin system is activated in liver cirrhosis, linked to endothelial dysfunction and inflammation.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-28239-2
- By:
- Publication type:
- Article
Covered Transjugular Intrahepatic Portosystemic Shunt Improves Hypersplenism-Associated Cytopenia in Cirrhosis.
- Published in:
- Digestive Diseases & Sciences, 2022, v. 67, n. 12, p. 5693, doi. 10.1007/s10620-022-07443-6
- By:
- Publication type:
- Article
HCV hotline facilitates Hepatitis C elimination during the COVID‐19 pandemic.
- Published in:
- Journal of Viral Hepatitis, 2022, v. 29, n. 12, p. 1062, doi. 10.1111/jvh.13746
- By:
- Publication type:
- Article
The impact of COVID-19 on liver transplantation programs in Austria.
- Published in:
- Wiener Klinische Wochenschrift, 2022, v. 134, n. 23/24, p. 875, doi. 10.1007/s00508-022-02105-z
- By:
- Publication type:
- Article
Treatment of Chronic Hepatitis D with Bulevirtide—A Fight against Two Foes—An Update.
- Published in:
- Cells (2073-4409), 2022, v. 11, n. 22, p. 3531, doi. 10.3390/cells11223531
- By:
- Publication type:
- Article
Hypoalbuminemia affects the spatio-temporal tissue distribution of ochratoxin A in liver and kidneys: consequences for organ toxicity.
- Published in:
- Archives of Toxicology, 2022, v. 96, n. 11, p. 2967, doi. 10.1007/s00204-022-03361-8
- By:
- Publication type:
- Article
Systemic inflammation is linked to liver fibrogenesis in patients with advanced chronic liver disease.
- Published in:
- Liver International, 2022, v. 42, n. 11, p. 2501, doi. 10.1111/liv.15365
- By:
- Publication type:
- Article
Editorial: pegylated interferon combined with bulevirtide for chronic hepatitis delta—new life for an old timer? Authors' reply.
- Published in:
- 2022
- By:
- Publication type:
- Case Study
Response‐guided long‐term treatment of chronic hepatitis D patients with bulevirtide—results of a "real world" study.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2022, v. 56, n. 1, p. 144, doi. 10.1111/apt.16945
- By:
- Publication type:
- Article
Age‐adjusted mortality and predictive value of liver chemistries in a Viennese cohort of COVID‐19 patients.
- Published in:
- Liver International, 2022, v. 42, n. 6, p. 1297, doi. 10.1111/liv.15274
- By:
- Publication type:
- Article
The 'Viennese epidemic' of acute HCV in the era of direct‐acting antivirals.
- Published in:
- Journal of Viral Hepatitis, 2022, v. 29, n. 5, p. 385, doi. 10.1111/jvh.13665
- By:
- Publication type:
- Article
Distinct prognostic value of different portal hypertension-associated features in patients with primary biliary cholangitis.
- Published in:
- Journal of Gastroenterology, 2022, v. 57, n. 2, p. 99, doi. 10.1007/s00535-021-01839-3
- By:
- Publication type:
- Article
Long-Term Outcome of HBV-Infected Patients with Clinically Significant Portal Hypertension Achieving Viral Suppression.
- Published in:
- Journal of Personalized Medicine, 2022, v. 12, n. 2, p. N.PAG, doi. 10.3390/jpm12020239
- By:
- Publication type:
- Article
Effect of liver resection-induced increases in hepatic venous pressure gradient on development of postoperative acute kidney injury.
- Published in:
- BMC Nephrology, 2022, v. 23, n. 1, p. 1, doi. 10.1186/s12882-021-02658-7
- By:
- Publication type:
- Article
Effect of liver resection-induced increases in hepatic venous pressure gradient on development of postoperative acute kidney injury.
- Published in:
- BMC Nephrology, 2022, v. 23, n. 1, p. 1, doi. 10.1186/s12882-021-02658-7
- By:
- Publication type:
- Article
Effect of liver resection-induced increases in hepatic venous pressure gradient on development of postoperative acute kidney injury.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Cirrhosis-Associated RAS-Inflammation-Coagulation Axis Anomalies: Parallels to Severe COVID-19.
- Published in:
- Journal of Personalized Medicine, 2021, v. 11, n. 12, p. 1264, doi. 10.3390/jpm11121264
- By:
- Publication type:
- Article
Review article: therapeutic aspects of bile acid signalling in the gut‐liver axis.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2021, v. 54, n. 10, p. 1243, doi. 10.1111/apt.16602
- By:
- Publication type:
- Article
Epidemiological trends of HBV and HDV coinfection among Viennese HIV+ patients.
- Published in:
- Liver International, 2021, v. 41, n. 11, p. 2622, doi. 10.1111/liv.15018
- By:
- Publication type:
- Article